Prudential Financial Inc. Decreases Stock Position in Integer Holdings Co. (NYSE:ITGR)

Prudential Financial Inc. cut its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,869 shares of the medical equipment provider's stock after selling 4,726 shares during the quarter. Prudential Financial Inc. owned about 0.12% of Integer worth $5,283,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ITGR. Jane Street Group LLC grew its position in shares of Integer by 23.3% in the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock valued at $19,682,000 after purchasing an additional 28,572 shares in the last quarter. Verition Fund Management LLC grew its holdings in Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider's stock valued at $451,000 after buying an additional 515 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after acquiring an additional 183 shares during the last quarter. KBC Group NV raised its holdings in shares of Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock worth $212,000 after acquiring an additional 726 shares during the period. Finally, Lord Abbett & CO. LLC boosted its position in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after acquiring an additional 9,754 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Citigroup raised their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, December 11th. Raymond James assumed coverage on shares of Integer in a research report on Friday, March 28th. They set an "outperform" rating and a $145.00 price target on the stock. Benchmark upped their price objective on Integer from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, February 21st. Truist Financial raised their target price on Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. Finally, KeyCorp increased their price target on Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, Integer has a consensus rating of "Moderate Buy" and an average target price of $148.56.

Integer Trading Down 1.9 %

Shares of NYSE ITGR traded down $2.20 during trading on Friday, reaching $113.87. The stock had a trading volume of 1,211,284 shares, compared to its average volume of 332,815. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The company has a market cap of $3.83 billion, a P/E ratio of 33.89, a PEG ratio of 1.72 and a beta of 1.24. Integer Holdings Co. has a fifty-two week low of $107.11 and a fifty-two week high of $146.36. The business's 50-day moving average price is $128.00 and its 200-day moving average price is $131.73.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. On average, equities research analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.